Exploring insulin analogue safety and effectiveness in a Maghrebian cohort with type 2 diabetes: results from the A1chieve study
-
Add time:09/06/2019 Source:sciencedirect.com
AimTo evaluate the safety and effectiveness of insulin analogues in patients with type 2 diabetes (T2D) from Morocco, Algeria and Tunisia that formed the Maghrebian cohort of the 24-week, non-interventional A1chieve study.
We also recommend Trading Suppliers and Manufacturers of INSULIN LISPRO (5.97 MG) (cas 133107-64-9). Pls Click Website Link as below: cas 133107-64-9 suppliers
Prev:Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70
Next:Developing a Pulmonary Insulin Delivery System for Patients with Diabetes) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Developing a Pulmonary Insulin Delivery System for Patients with Diabetes09/07/2019
- Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/7009/05/2019
- Inhaled dry powder insulin for the treatment of diabetes mellitus09/04/2019
- Establishment of the First National Reference Standard for Insulin Lispro: Report of a collaborative study09/03/2019
-
Health and Chemical more >